序号 | 股票代码 | 股票简称 | 纳入时间 | 申万1级 | 申万2级 | 申万3级 | 价格
|
市盈率
|
市盈率ttm
|
市净率
|
股息率
|
市值(亿元)
|
归母净利润同比增长(06-30)
|
归母净利润同比增长(03-31)
|
营业收入同比增长(06-30)
|
营业收入同比增长(03-31)
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 603456.SH | 九洲药业 | 2023-07-06 | — | — | 医疗研发外包 | 18.93 | 27.78 | 25.63 | 1.97 | 2.62% | 168.37 | 10.70% | 5.68% | 3.86% | 0.98% |
2 | 300363.SZ | 博腾股份 | 2014-02-12 | — | — | 医疗研发外包 | 24.54 | — | — | 2.53 | — | 133.86 | 115.91% | 95.48% | 19.88% | 18.21% |
3 | 301520.SZ | 万邦医药 | 2023-10-10 | — | — | 医疗研发外包 | 41.55 | 32.39 | 48.33 | 1.84 | 0.84% | 27.70 | -51.28% | -60.09% | -21.57% | -21.20% |
4 | 600721.SH | 百花医药 | 2008-01-25 | — | — | 医疗研发外包 | 8.91 | 82.6 | 77.34 | 4.36 | — | 34.26 | 12.46% | 0.28% | 2.95% | 6.65% |
5 | 300149.SZ | 睿智医药 | 2010-12-29 | — | — | 医疗研发外包 | 11.41 | — | — | 4.59 | — | 56.82 | 140.35% | 126.09% | 14.75% | 11.37% |
6 | 688238.SH | 和元生物 | 2023-09-25 | — | — | 医疗研发外包 | 7.62 | — | — | 3.22 | — | 49.46 | 7.74% | -41.04% | 6.01% | -11.29% |
7 | 301096.SZ | 百诚医药 | 2021-12-27 | — | — | 医疗研发外包 | 58.0 | — | — | 2.45 | — | 63.35 | -97.69% | -152.59% | -36.70% | -40.32% |
8 | 301201.SZ | 诚达药业 | 2022-01-27 | — | — | 医疗研发外包 | 29.71 | — | — | 2.16 | 0.66% | 45.97 | -49.06% | -107.51% | 11.24% | -24.37% |
9 | 301333.SZ | 诺思格 | 2022-08-09 | — | — | 医疗研发外包 | 53.46 | 36.82 | 36.15 | 2.74 | 0.3% | 51.63 | 4.45% | 13.12% | 0.18% | -2.53% |
10 | 301509.SZ | 金凯生科 | 2023-08-10 | — | — | 医疗研发外包 | 35.47 | 110.65 | 54.58 | 1.97 | 1.13% | 42.72 | 123.61% | 183.24% | 32.98% | 41.83% |
11 | 300347.SZ | 泰格医药 | 2012-08-24 | — | — | 医疗研发外包 | 59.29 | 126.01 | 172.68 | 2.49 | 0.5% | 510.50 | -22.22% | -29.61% | -3.21% | -5.79% |
12 | 688710.SH | 益诺思 | 2024-09-10 | — | — | 医疗研发外包 | 47.39 | 45.21 | 180.83 | 2.86 | — | 66.81 | -115.88% | -90.33% | -38.04% | -29.35% |
13 | 688202.SH | 美迪西 | 2023-09-25 | — | — | 医疗研发外包 | 65.69 | — | — | 4.23 | — | 88.26 | 81.63% | 61.27% | 3.64% | 2.92% |
14 | 688265.SH | 南模生物 | 2023-09-25 | — | — | 医疗研发外包 | 50.26 | 603.26 | 115.91 | 2.32 | — | 39.18 | 298.69% | 92.50% | 10.69% | 6.59% |
15 | 002821.SZ | 凯莱英 | 2016-11-25 | — | — | 医疗研发外包 | 107.76 | 40.95 | 36.41 | 2.27 | 1.02% | 388.58 | 23.71% | 15.83% | 18.20% | 10.10% |
16 | 688131.SH | 皓元医药 | 2023-09-25 | — | — | 医疗研发外包 | 79.22 | 83.35 | 59.38 | 5.69 | — | 168.02 | 115.55% | 272.28% | 24.20% | 20.05% |
17 | 300759.SZ | 康龙化成 | 2019-02-11 | — | — | 医疗研发外包 | 33.57 | 33.29 | 43.21 | 4.18 | 0.6% | 596.94 | -37.00% | 32.54% | 14.93% | 16.03% |
18 | 688046.SH | 药康生物 | 2023-09-25 | — | — | 医疗研发外包 | 18.42 | 68.77 | 72.35 | 3.48 | — | 75.52 | -7.12% | 1.70% | 10.11% | 8.76% |
19 | 300404.SZ | 博济医药 | 2015-05-04 | — | — | 医疗研发外包 | 9.92 | 132.91 | 269.13 | 3.78 | 0.12% | 38.25 | -48.33% | -76.38% | 5.88% | -17.06% |
20 | 300683.SZ | 海特生物 | 2024-07-31 | — | — | 医疗研发外包 | 34.1 | — | — | 1.9 | 0.38% | 44.63 | -72.10% | 15.81% | -3.36% | 18.79% |
21 | 688621.SH | 阳光诺和 | 2023-09-25 | — | — | 医疗研发外包 | 66.66 | 42.08 | 47.05 | 6.69 | — | 74.66 | -12.61% | -59.34% | 4.87% | -8.49% |
22 | 300725.SZ | 药石科技 | 2017-11-17 | — | — | 医疗研发外包 | 40.68 | 43.32 | 49.19 | 2.05 | 0.59% | 95.11 | -26.54% | -27.67% | 23.48% | 20.55% |
23 | 301257.SZ | 普蕊斯 | 2022-05-24 | — | — | 医疗研发外包 | 45.85 | 34.04 | 34.28 | 2.99 | 0.55% | 36.22 | -1.40% | -67.32% | -1.08% | -4.37% |
24 | 688073.SH | 毕得医药 | 2023-09-25 | — | — | 医疗研发外包 | 76.9 | 59.52 | 50.28 | 3.59 | — | 69.89 | 41.60% | 17.71% | 17.91% | 12.83% |
25 | 301230.SZ | 泓博医药 | 2022-11-08 | — | — | 医疗研发外包 | 34.19 | 279.37 | 184.49 | 4.7 | 1.24% | 47.72 | 54.99% | 226.47% | 32.73% | 29.61% |
26 | 603127.SH | 昭衍新药 | 2017-09-01 | — | — | 医疗研发外包 | 36.93 | 373.65 | 90.82 | 3.42 | 0.08% | 276.78 | 135.90% | 115.11% | -21.28% | -11.54% |
27 | 603259.SH | 药明康德 | 2018-05-15 | — | — | 医疗研发外包 | 102.92 | 32.14 | 22.06 | 4.69 | 1.65% | 3037.69 | 101.92% | 89.06% | 20.64% | 20.96% |
28 | 688222.SH | 成都先导 | 2023-09-25 | — | — | 医疗研发外包 | 23.31 | 181.86 | 102.41 | 6.54 | — | 93.40 | 390.72% | 102.90% | 16.58% | -0.60% |
免责声明:数据相关栏目所收集数据,均来自第三方个人或企业公开数据以及国家统计网站公开发布数据,数据由计算机技术自动收集更新再由作者校验,作者将尽力校验,但不能保证数据的完全准确。 阅读本栏目的用户必须明白,图表所示结果或标示仅供学习参考使用,均不构成交易依据。任何据此进行交易等行为,而引致的任何损害后果,本站概不负责。